Healthcare management provider Omnicell acquires Aesynt for $275M

Medication and healthcare systems solution provider, Omnicell has announced its agreement to acquire Pennsylvania based enterprise medication management tools provider, Aesynt, for $275 million.

Francisco Partners, the parent company had acquired Aesynt in October 2013. Aesynt provides enterprise software which involve medication logistics management software, automated procurement and order management, and reporting & analytics for inventory management and medication utilization. It also provides full suite of automated and semi-automated solutions for the IV room; central pharmacy solutions; and point of care solutions.

“Aesynt brings distinct capacities in dispensing systems, central pharmacy robotics, IV robotics and analytics,” said Randall Lipps, CEO of Omnicell.

“We expect that as a combined entity we can accelerate innovation in the marketplace by leveraging the combined strengths of the Aesynt and Omnicell teams. Choice, innovation and value make this a great acquisition for Omnicell and our customers.”

The combined company would support approximately 4,000 acute care facilities worldwide, have annual revenues of over $650 million and have approximately 2,200 employees.

The completion of the transaction is subject to Hart-Scott-Rodino review and the satisfaction of other customary closing conditions, and is expected to close in 2016. Aesynt recorded approximately $182 million of revenue and approximately $20 million of adjusted EBITDA (unaudited) in the last twelve months ended June 30, 2015.

Abhinav Mohapatra

An author who has a keen interest for the ‘off-beat’ <!--more-->An author who has a keen interest for the ‘off-beat’, he has covered and explored multiple facets of the marketing, advertising

Great! You've successfully subscribed.
Great! Next, complete checkout for full access.
Welcome back! You've successfully signed in.
Success! Your account is fully activated, you now have access to all content.